Single-dose GnRH agonist administration in the luteal phase of GnRH antagonist cycles: A prospective randomized study

Reproductive BioMedicine Online

Volumn 19, Issue 4, 2009, Pages 472-477

  Isik, A Z ^a   Caglar, G S ^b   Sozen, E ^a   Akarsu, C ^a   Tuncay, G ^a   Ozbicer, T ^a   Vicdan, K ^a  

^a Private Ankara IVF Center   (Turkey)

^b UFUK UNIVERSITY   (Turkey)

Author keywords

GnRH agonist; GnRH antagonist; Luteal phase

Indexed keywords

CETRORELIX; CHORIONIC GONADOTROPIN; CHORIONIC GONADOTROPIN BETA SUBUNIT; FOLLITROPIN; GANIRELIX; GONADORELIN ANTAGONIST; GONADOTROPIN; HUMAN MENOPAUSAL GONADOTROPIN; LEUPRORELIN; LUTEINIZING HORMONE; PROGESTERONE; RECOMBINANT CHORIONIC GONADOTROPIN; RECOMBINANT FOLLITROPIN;

ADULT; ARTICLE; BIRTH RATE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE DURATION; DRUG EFFECT; EMBRYO TRANSFER; FEMALE; FEMALE INFERTILITY; FERTILIZATION; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; LIVE BIRTH; LUTEAL PHASE; MAJOR CLINICAL STUDY; METAPHASE; MULTIPLE PREGNANCY; NIDATION; OOCYTE; OOCYTE RETRIEVAL; OVARY FOLLICLE; OVULATION INDUCTION; PREGNANCY; PREGNANCY RATE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; TREATMENT DURATION;

EID: 70449382804     PISSN: 14726483     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rbmo.2009.04.001     Document Type: Article

References (23)

1. Albano C, Smitz J, Tournaye H et al. 1999 Luteal phase and clinical outcome after human menopausal onadotrophin/gonadotrophin releasing hormone antagonist treatment for ovarian stimulation in in vitro fertilization/ intracytoplasmic sperm injection cycles. Human Reproduction 14, 1426-1430. (Pubitemid 129754852)
2. Beckers NG, Macklon NS, Eijkemans MJ et al. 2003 Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment. Journal of Clinical Endocrinology and Metabolism 88, 4186-4192.
3. Chillik CF, Itskovitz J, Hahn DW et al. 1987 Characterizing pituitary response to a gonadotropin-releasing hormone (GnRH) antagonist in monkeys: tonic follicle-stimulating hormone/luteinizing hormone secretion versus acute GnRH challenge tests before, during, and after treatment. Fertility and Sterility 48, 480-485. (Pubitemid 17140000)
4. Csapo AI, Pulkkinen MO, Ruttner B et al. 1972 The significance of the human corpus luteum in pregnancy maintenance. I. Preliminary studies. American Journal of Obstetrics and Gynecology 112, 1061-1067.
5. Daya S, Gunby J 2004 Luteal phase support in assisted reproduction cycles. Cochrane Database of Systematic Reviews CD004830.
6. Ditkoff EC, Cassidenti DL, Paulson RJ et al. 1991 The gonadotropin-releasing hormone antagonist (Nal-Glu)acutely blocks the luteinizing hormone surge but allows for resumption offolliculogenesis in normal women. American Journal of Obstetrics and Gynecology 165, 1811-1817.
7. Fattinger KE, Verotta D, Porchet HC et al. 1996 Modeling a bivariate control system: LH and testosterone response to the GnRH antagonist antide. American Journal of Physiology 271, E775-E787.
8. Felberbaum RE, Reissmann T, Küpker W et al. 1995 Preserved pituitary response under ovarian stimulation with HMG and GnRH antagonists (Cetrorelix) in women with tubal infertility. European Journal of Obstetrics and Gynecology and Reproductive Biology 61, 151-155.
9. Friedler S, Gilboa S, Schachter M et al. 2006 Luteal phase characteristics following GnRH antagonist or agonist treatment - a comparative study. Reproductive Bio Medicine Online 12, 27-32. (Pubitemid 43109352)
10. Gordon K, Williams RF, Danforth DR, Hodgen GD 1990 A novel regimen of gonadotropin-releasing hormone (GnRH) antagonist plus pulsatile GnRH: controlled restoration of gonadotropin secretion and ovulation induction. Fertility and Sterility 54, 1140-1145.
11. Hugues JN, Cedrin-Durnerin I, Bstandig B et al. 2006 Administration of gonadotropin-releasing hormone agonist during the luteal-phase of GnRH antagonist IVF cycles. Abstracts of the 22nd Annual Meeting of ESHRE, 18-21 June 2006, Prague, Czech Republic, O-007.
12. Kolibianakis EM, Bourgain C, Platteau P et al. 2003 Abnormal endometrial development occurs during the luteal phase of nonsupplemented donor cycles treated with recombinant follicle-stimulating hormone and gonadotropin-releasing hormone antagonists. Fertility and Sterility 80, 464-466. (Pubitemid 36959814)
13. Lambalk CB, Homburg R 2006 GnRH agonist for luteal support in IVF? Setting the balance between enthusiasm and caution. Human Reproduction 21, 2580-2582. (Pubitemid 44542148)
14. Macklon NS, Fauser BC 2000 Impact of ovarian hyperstimulation on the luteal phase. Journal of Reproduction and Fertility 55, 101-108.
15. Oberye JJ, Mannaerts BM, Huisman JA, Timmer CJ 1999 Pharmacokinetic and pharmacodynamic characteristics of ganirelix (Antagon/Orgalutran). Part II. Dose-proportionality and gonadotropin suppression after multiple doses of ganirelix in healthy female volunteers. Fertility and Sterility 72, 1006-1012.
16. Pirard C, Donnez J, Loumaye E 2006 GnRH agonist as luteal phase support in assisted reproduction technique cycles: results of a pilot study. Human Reproduction 21, 1894-1900. (Pubitemid 44028266)
17. Pirard C, Donnez J, Loumaye E 2005 GnRH agonist as novel luteal support: results of a randomized, parallel group, feasibility study using intranasal administration of buserelin. Human Reproduction 20, 1798-1804. (Pubitemid 40940990)
18. Pritts EA, Atwood AK 2002 Luteal phase support in infertility treatment: a meta-analysis of the randomized trials. Human Reproduction 17, 2287-2299.
19. Saadat P, Boostanfar R, Slatar C et al. 2004 Accelerated endometrial maturation in the luteal phase of cycles utilizing controlled ovarian hyperstimulation: impact of gonadotropin-releasing hormone agonists versus antagonists. Fertility and Sterility 82, 167-171. (Pubitemid 38968794)
20. Tavaniotou A, Devroey P 2006 Luteal hormonal profile of oocyte donors stimulated with a GnRH antagonist compared with natural cycles. Reproductive BioMedicine Online 13, 326-330. (Pubitemid 44375409)
21. Tesarik J, Hazout A, Mendoza-Tesarik R et al. 2006 Beneficial effect of luteal-phase GnRH agonist administration on embryo implantation after ICSI in both GnRH agonist- and antagonist-treated ovarian stimulation cycles. Human Reproduction 21, 2572-2579. (Pubitemid 44548853)
22. Tesarik J, Hazout A, Mendoza C 2004 Enhancement of embryo developmental potential by a single administration of GnRH agonist at the time of implantation. Human Reproduction 19, 1176-1180. (Pubitemid 38618501)
23. Veeck LL 1999 An Atlas of Human Gametes and Conceptuses: An Illustrated Reference for Assisted Reproductive Technology. New York: Parthenon Publishing; 1999.